A worker scans the barcode on the Avifavir antiviral drug approved to treat patients suffering from the coronavirus, at a storage facility at the unknown location, Russia. The Russian Direct Investment Fund (RDIF) and the ChemRar pharmaceutical company said on June 11 they started delivering Avifavir medication against COVID-19 to hospitals across the country. Avifavir, created on the basis of Favipiravir, is one of the two drugs for COVID-19 treatment registered globally. In early June, the Russian Health Ministry said that the medication had proven 90 percent efficient during trials.
|Categories:||Science & Technology, Health, Social Issues, Human Interest|
|Feature:||Russia Coronavirus Antiviral Drug|
|Keywords:||SARS-CoV-2, COVID, COVID-19, virus, pandemic, epidemic, infection, 2019-nCoV, coronavirus, disease|
|Source:||Russian Direct Investment Fund (RDIF)|